These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 10832826)

  • 21. Selective use of whole breast radiotherapy after breast conserving surgery for invasive breast cancer and DCIS.
    Skandarajah AR; Bruce Mann G
    Surgeon; 2013 Oct; 11(5):278-85. PubMed ID: 23632044
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased cardio and cerebrovascular mortality in breast cancer patients treated with postmastectomy radiotherapy--25 year follow-up of a randomised trial from the South Sweden Breast Cancer Group.
    Killander F; Anderson H; Kjellén E; Malmström P
    Eur J Cancer; 2014 Sep; 50(13):2201-10. PubMed ID: 24951164
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DEGRO practical guidelines for radiotherapy of breast cancer I: breast-conserving therapy.
    Sautter-Bihl ML; Budach W; Dunst J; Feyer P; Haase W; Harms W; Sedlmayer F; Souchon R; Wenz F; Sauer R; ;
    Strahlenther Onkol; 2007 Dec; 183(12):661-6. PubMed ID: 18040609
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High local recurrence risk is not associated with large survival reduction after postmastectomy radiotherapy in high-risk breast cancer: a subgroup analysis of DBCG 82 b&c.
    Kyndi M; Overgaard M; Nielsen HM; Sørensen FB; Knudsen H; Overgaard J
    Radiother Oncol; 2009 Jan; 90(1):74-9. PubMed ID: 18471914
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Local relapse in young (< or = 40 years) women with breast cancer after mastectomy or breast conserving surgery: 15-year results].
    Fodor J; Mózsa E; Zaka Z; Polgár C; Major T
    Magy Onkol; 2005; 49(3):203, 205-8. PubMed ID: 16249814
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial.
    Bartelink H; Maingon P; Poortmans P; Weltens C; Fourquet A; Jager J; Schinagl D; Oei B; Rodenhuis C; Horiot JC; Struikmans H; Van Limbergen E; Kirova Y; Elkhuizen P; Bongartz R; Miralbell R; Morgan D; Dubois JB; Remouchamps V; Mirimanoff RO; Collette S; Collette L;
    Lancet Oncol; 2015 Jan; 16(1):47-56. PubMed ID: 25500422
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial.
    Overgaard M; Jensen MB; Overgaard J; Hansen PS; Rose C; Andersson M; Kamby C; Kjaer M; Gadeberg CC; Rasmussen BB; Blichert-Toft M; Mouridsen HT
    Lancet; 1999 May; 353(9165):1641-8. PubMed ID: 10335782
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ovarian ablation for early breast cancer.
    Early Breast Cancer Trialists' Collaborative Group
    Cochrane Database Syst Rev; 2000; (2):CD000485. PubMed ID: 10796722
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radiotherapy to regional nodes in early breast cancer: an individual patient data meta-analysis of 14 324 women in 16 trials.
    Early Breast Cancer Trialists' Collaborative Group (EBCTCG)
    Lancet; 2023 Nov; 402(10416):1991-2003. PubMed ID: 37931633
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A positive margin is not always an indication for radiotherapy after mastectomy in early breast cancer.
    Truong PT; Olivotto IA; Speers CH; Wai ES; Berthelet E; Kader HA
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):797-804. PubMed ID: 14967436
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Maximum androgen blockade in advanced prostate cancer: an overview of the randomised trials. Prostate Cancer Trialists' Collaborative Group.
    Lancet; 2000 Apr; 355(9214):1491-8. PubMed ID: 10801170
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ovarian ablation for early breast cancer.
    Early Breast Cancer Trialists' Collaborative Group
    Cochrane Database Syst Rev; 2000; (3):CD000485. PubMed ID: 10908474
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patient and anatomical selectivity in postoperative radiotherapy for early breast cancer: a British perspective.
    Ebbs SR; Yarnold JR
    Semin Surg Oncol; 1992; 8(3):167-71. PubMed ID: 1386682
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of radiotherapy fraction size on tumour control in patients with early-stage breast cancer after local tumour excision: long-term results of a randomised trial.
    Owen JR; Ashton A; Bliss JM; Homewood J; Harper C; Hanson J; Haviland J; Bentzen SM; Yarnold JR
    Lancet Oncol; 2006 Jun; 7(6):467-71. PubMed ID: 16750496
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DEGRO practical guidelines for radiotherapy of breast cancer II. Postmastectomy radiotherapy, irradiation of regional lymphatics, and treatment of locally advanced disease.
    Sautter-Bihl ML; Souchon R; Budach W; Sedlmayer F; Feyer P; Harms W; Haase W; Dunst J; Wenz F; Sauer R
    Strahlenther Onkol; 2008 Jul; 184(7):347-53. PubMed ID: 19016032
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Who should not undergo breast conservation?
    Nijenhuis MV; Rutgers EJ
    Breast; 2013 Aug; 22 Suppl 2():S110-4. PubMed ID: 24074770
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk factors for regional nodal relapse in breast cancer patients with one to three positive axillary nodes.
    Yates L; Kirby A; Crichton S; Gillett C; Cane P; Fentiman I; Sawyer E
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):2093-103. PubMed ID: 21530101
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nodal ratios in node-positive breast cancer--long-term study to clarify discrepancy of role of supraclavicular and axillary regional radiotherapy.
    Tai P; Joseph K; Sadikov E; Mahmood S; Lien F; Yu E
    Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):662-6. PubMed ID: 17449196
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Postoperative loco-regional radiation therapy for breast cancer patients with four or more involved lymph nodes or extracapsular extension.
    Evron E; Barzily L; Rakowsky E; Ben-Baruch N; Sulkes J; Rizel S; Fenig E
    Isr Med Assoc J; 2005 Jul; 7(7):439-42. PubMed ID: 16011059
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adjuvant chemotherapy in oestrogen-receptor-poor breast cancer: patient-level meta-analysis of randomised trials.
    ; Clarke M; Coates AS; Darby SC; Davies C; Gelber RD; Godwin J; Goldhirsch A; Gray R; Peto R; Pritchard KI; Wood WC
    Lancet; 2008 Jan; 371(9606):29-40. PubMed ID: 18177773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.